JP2015520228A - Composition for improving hair and scalp conditions containing natural extract as active ingredient, and method for producing the same - Google Patents
Composition for improving hair and scalp conditions containing natural extract as active ingredient, and method for producing the same Download PDFInfo
- Publication number
- JP2015520228A JP2015520228A JP2015518348A JP2015518348A JP2015520228A JP 2015520228 A JP2015520228 A JP 2015520228A JP 2015518348 A JP2015518348 A JP 2015518348A JP 2015518348 A JP2015518348 A JP 2015518348A JP 2015520228 A JP2015520228 A JP 2015520228A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- composition
- extract
- scalp
- god
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9741—Pteridophyta [ferns]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/002—Preparations for repairing the hair, e.g. hair cure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本発明は、天然抽出物を有効成分として含む毛髪及び頭皮状態改善用組成物、その製造方法及び天然抽出物を投与して、毛髪及び頭皮の状態を改善する方法に関するものであって、本発明による毛髪及び頭皮状態改善用組成物は、天然抽出物を有効成分として含んでいて、副作用ないし毒性の恐れがなく、手術を要さず、経済的かつ容易に適用可能である。The present invention relates to a hair and scalp condition improving composition containing a natural extract as an active ingredient, a method for producing the same, and a method for improving the condition of hair and scalp by administering the natural extract. The composition for improving hair and scalp condition according to No. 1 contains a natural extract as an active ingredient, has no fear of side effects or toxicity, does not require surgery, and can be applied economically and easily.
Description
本発明は、天然抽出物を有効成分として含む毛髪及び頭皮状態改善用組成物、及びその製造方法に係り、また、本発明の天然抽出物を投与して、毛髪及び頭皮の状態を改善する方法に関する。 The present invention relates to a hair and scalp condition improving composition containing a natural extract as an active ingredient, and a method for producing the same, and a method for improving the condition of hair and scalp by administering the natural extract of the present invention. About.
脱毛症の最も平凡な類型である男性脱毛症は、男性ホルモンの1つであるテストステロン(testosterone)が5α還元酵素(testosterone 5α−reductase)によって活性型男性ホルモンであるジヒドロテストステロン(dihydrotestosterone;DHT)に切替えられ、このように活性化されたジヒドロテストステロンがアンドロゲン受容体と結合して、毛嚢細胞のタンパク質合成を遅延させて、毛嚢の成長期が短縮され、毛嚢を萎縮させて、脱毛を誘発する。また、アンドロゲン性脱毛過程で皮脂が過剰生成され、その結果として、頭皮では炎症を伴った脱毛が表れる(非特許文献1参照)。 Male alopecia, the most common type of alopecia, is dihydrotestosterone (DHT), one of the male hormones, testosterone (testosterone), which is the active male hormone by 5α-reductase (testosterone 5α-reductase). The switched and activated dihydrotestosterone binds to the androgen receptor, delays protein synthesis in the hair follicle cells, shortens the hair follicle growth phase, shrinks the hair follicles, and removes hair loss. Trigger. In addition, sebum is excessively generated in the process of androgenic hair loss, and as a result, hair loss accompanied by inflammation appears in the scalp (see Non-Patent Document 1).
通常の脱毛治療法は、毛髪移植法である。すなわち、毛髪が出ている皮膚のプラグ(plug)を毛髪が成長する頭皮部位から脱毛部位に移植する方法である。このような方法は、時間が浪費され、相対的に苦痛が伴うだけではなく、費用が多くかかる。他の非薬物治療法には、紫外線照射及び運動療法が含まれる。
更に他の脱毛治療法としては、薬物療法がある。米国のメルク社は、5α還元酵素の作用を阻害して、ジヒドロテストステロン(DHT)の生成を抑制させる薬として、フィナステリドを経口投与用として製造した発毛剤を販売している。しかし、これは、ステロイド系薬物による副作用が発生するという問題点がある。
また、フィトエストロゲン(phytoestrogen)の一種であるダイゼイン(daidzein)の主な代謝産物であるエクオール(equol)が、テストステロンには何らの影響なしにジヒドロテストステロン(DHT)と直接結合することによって、男性ホルモンであるジヒドロテストステロン(DHT)の行路を遮断するという内容が報告されている。
The usual hair loss treatment method is a hair transplantation method. That is, it is a method of transplanting a skin plug from which hair has come out from the scalp site where the hair grows to the hair removal site. Such a method is not only time consuming and relatively painful, but also expensive. Other non-drug treatments include ultraviolet radiation and exercise therapy.
Still another hair loss treatment is drug therapy. Merck, Inc. of the United States sells a hair growth agent manufactured by using finasteride for oral administration as a drug that inhibits the action of 5α reductase and suppresses the production of dihydrotestosterone (DHT). However, this has a problem that side effects due to steroidal drugs occur.
In addition, equol, which is a major metabolite of daidzein, a kind of phytoestrogens, directly binds to dihydrotestosterone (DHT) without any influence on testosterone, thereby causing a male hormone. The content of blocking the path of dihydrotestosterone (DHT) is reported.
したがって、経済的でありながらも、各種の副作用ないし毒性の恐れがない天産物由来の治療剤の開発が要求されている。 Therefore, there is a demand for the development of a natural product-derived therapeutic agent that is economical but does not cause various side effects or toxicity.
そこで、本発明者らは、前記問題点を解決するために、実験を通じて、蘆根、芍薬、茯神、石韋、ソバナ(薺バナ)、センナ葉、紫檀香、草果、沢瀉、貫衆、亜麻仁、葛花、きょうおう(姜おう)、かろにん(か楼仁)、麻仁及び蘇木抽出物が、5α還元酵素の効能を抑制することによって、毛髪の成長を促進するという事実を確認し、前記抽出物から毛髪及び頭皮状態改善用組成物と、その製造方法、毛髪及び頭皮状態改善方法を明らかにした。 Therefore, in order to solve the above-mentioned problems, the present inventors have conducted experiments through Sone, Acupuncture, Akagami, Ishizuchi, Sobana, Senna leaf, Rosewood incense, Grass, Sawaka, Insane , Flaxseed, kuzuhana, kaoru, karonin, hemp and sugi extracts promote the growth of hair by inhibiting the efficacy of 5α reductase From the extract, the composition for improving hair and scalp conditions, its production method, and the method for improving hair and scalp conditions were clarified.
本発明は、天然抽出物を有効成分として含む毛髪及び頭皮状態改善用組成物、及びその製造方法を提供することを目的とする。
また、本発明は、蘆根、芍薬、茯神、石韋、ソバナ(薺バナ)、センナ葉、紫檀香、草果、沢瀉、貫衆、亜麻仁、葛花、きょうおう(姜おう)、かろにん(か楼仁)、麻仁及び蘇木からなる群から選択される1種以上の抽出物を脱毛を有した個体に投与する段階を含む毛髪及び頭皮状態改善方法を提供することを目的とする。
An object of this invention is to provide the composition for hair and scalp condition improvement which contains a natural extract as an active ingredient, and its manufacturing method.
In addition, the present invention includes radish, glaze, god of gods, sarcophagus, sobana, senna leaf, rosewood incense, grass, swamps, mulberry, flaxseed, kuzuhana, kyoou An object of the present invention is to provide a method for improving hair and scalp conditions, comprising the step of administering one or more extracts selected from the group consisting of garlic, hemp seed and soki to an individual having hair loss. And
本発明によって、5α還元酵素阻害効果に優れた天然抽出物を有効成分として含む毛髪及び頭皮状態改善用組成物、その製造方法及び天然抽出物を投与して、毛髪及び頭皮の状態を改善する方法が提供される。前記毛髪及び頭皮状態改善用組成物は、天然抽出物を有効成分として含んでいて、副作用ないし毒性の恐れがなく、手術を要さず、経済的かつ容易に適用可能である。 According to the present invention, a hair and scalp condition improving composition comprising a natural extract having an excellent inhibitory effect on 5α reductase as an active ingredient, a method for producing the same, and a method for improving the condition of hair and scalp by administering the natural extract Is provided. The hair and scalp condition improving composition contains a natural extract as an active ingredient, has no fear of side effects or toxicity, does not require surgery, and can be applied economically and easily.
前記のような目的を果たすために、本発明の望ましい一具体例は、蘆根、芍薬、茯神、石韋、ソバナ(薺バナ)、センナ葉、紫檀香、草果、沢瀉、貫衆、亜麻仁、葛花、きょうおう(姜おう)、かろにん(か楼仁)、麻仁及び蘇木からなる群から選択される1種以上の抽出物を有効成分として含む毛髪及び頭皮状態改善用組成物を提供する。 In order to achieve the above-mentioned purpose, a preferred embodiment of the present invention includes a root, a glaze, a god, a sarcophagus, a sobana, a senna leaf, a rosewood incense, a grass fruit, a sardine, an intruder, For improving hair and scalp conditions containing as an active ingredient at least one extract selected from the group consisting of flaxseed, kuzuhana, kyouou, karonin, hemp and sugi A composition is provided.
また、本発明の他の望ましい一具体例は、前記組成物を含むヘア用組成物を提供する。
また、本発明の更に他の望ましい一具体例は、蘆根、芍薬、茯神、石韋、ソバナ(薺バナ)、センナ葉、紫檀香、草果、沢瀉、貫衆、亜麻仁、葛花、きょうおう(姜おう)、かろにん(か楼仁)、麻仁及び蘇木からなる群から選択される1種以上の抽出物を脱毛を有した個体に投与する段階を含む毛髪及び頭皮状態改善方法を提供する。
Another desirable embodiment of the present invention provides a hair composition comprising the composition.
Further, another desirable specific example of the present invention is as follows: Sone, glaze, 茯神, 石 韋, sovana (soba), senna leaf, rosewood incense, herbaceous fruits, swallows, injuries, flaxseed, kuzuhana, Hair and scalp conditions including the step of administering one or more extracts selected from the group consisting of Kyoou, Karonin, hemp and Soki to individuals with hair loss Provide improvement methods.
また、本発明の更に他の望ましい一具体例は、蘆根、芍薬、茯神、石韋、ソバナ(薺バナ)、センナ葉、紫檀香、草果、沢瀉、貫衆、亜麻仁、葛花、きょうおう(姜おう)、かろにん(か楼仁)、麻仁及び蘇木からなる群から選択される1種以上を水、エタノール、又はこれらの混合溶媒で抽出する段階と、前記抽出段階を通じて得られた抽出物を減圧濾過する段階と、前記濾過段階を通じて得られた濾液を減圧濃縮する段階と、を含む前記毛髪及び頭皮状態改善用組成物の製造方法を提供する。 Further, another desirable specific example of the present invention is as follows: Sone, glaze, 茯神, 石 韋, sovana (soba), senna leaf, rosewood incense, herbaceous fruits, swallows, injuries, flaxseed, kuzuhana, Extracting one or more selected from the group consisting of Kyoou (Kouou), Karonin (Karojin), hemp and Soki with water, ethanol, or a mixed solvent thereof, and the extraction step A method for producing the hair and scalp condition improving composition comprising: a step of subjecting the extract obtained through filtration under reduced pressure; and a step of concentrating the filtrate obtained through the filtration step under reduced pressure.
以下、本発明をより詳しく説明する。
5α還元酵素は、男性ホルモンの1つであるテストステロンを活性型男性ホルモンであるジヒドロテストステロン(DHT)に切替え、このように活性化されたジヒドロテストステロンがアンドロゲン受容体と結合して、毛嚢細胞のタンパク質合成を遅延させて、毛嚢の成長期が短縮され、毛嚢を萎縮させて、脱毛を誘発する。また、アンドロゲン性脱毛過程で皮脂が過剰生成され、その結果として、頭皮では炎症を伴った脱毛が表れる[Dennis A.15 Holt,et.al,J Med.Chem.,33,943,(1990)]。
Hereinafter, the present invention will be described in more detail.
5α reductase converts testosterone, which is one of the male hormones, to dihydrotestosterone (DHT), which is the active male hormone, and the activated dihydrotestosterone binds to the androgen receptor, thereby Delays protein synthesis, shortens hair follicle growth phase, causes hair follicles to shrink and induces hair loss. In addition, sebum is excessively produced in the process of androgenic hair loss, and as a result, hair loss accompanied by inflammation appears in the scalp [Dennis A. et al. 15 Holt, et. al, J Med. Chem. 33, 943, (1990)].
したがって、前記5α還元酵素を阻害することによって、脱毛を防止し、発毛を促進し、また、皮脂分泌及び頭垢を防止又は減少させ、頭皮炎症も予防又は改善させることができる(Olsen EA,Hordinsky M,Whiting D,et al“The importance of dual 5alpha−reductaseinhibition in the treatment of MPB:results of a randomized placebo−controlled study of dutasteride versus finasteride”.J Am Acad Dermatol.55(6),2006,Leyden,James;Dunlap,Frank;Miller,Bruce;Winters,Peter;Lebwohl,Mark;Hecker,David;Kraus,Stephen;Baldwin,Hilary et al.“Finasteride in the treatment of men with frontal male pattern hair loss”.Journal of the American Academy of Dermatology 40(6 Pt 1):930−7.,1999)。 Therefore, by inhibiting the 5α reductase, hair loss can be prevented, hair growth can be promoted, sebum secretion and scalp can be prevented or reduced, and scalp inflammation can be prevented or improved (Olsen EA, Hordinsky M, Whiting D, et al "The importance of dual 5alpha-reductaseinhibition in the treatment of MPB: results of a randomized placebo-controlled study of dutasteride versus finasteride" .J Am Acad Dermatol.55 (6), 2006, Leyden, James; Dunlap, Frank; Miller, Br uce; Winters, Peter; Lebwohl, Mark; Hecker, David; Kraus, Stephen;. Baldwin, Hilary et al "Finasteride in the treatment of men with frontal male pattern hair loss" .Journal of the American Academy of Dermatology 40 (6 Pt 1): 930-7, 1999).
本発明者らが、毛髪及び頭皮の状態改善と関連して所望しない副作用が頻繁に発生する既存の薬剤を代替しうる副作用ないし毒性がなく、毛髪及び頭皮の状態改善に優れた効果を有した新たな形態の天産物由来の製剤の開発のために研究した結果、特定薬材の抽出物及びその分画物が、5α還元酵素阻害効果が著しく優れることを知見して、本発明を完成した。 The inventors have no side effects or toxicity that can replace existing drugs that frequently cause undesirable side effects in connection with the improvement of the condition of hair and scalp, and have an excellent effect on improving the condition of hair and scalp. As a result of research for the development of a new form of natural product-derived preparation, the inventors have found that the extract of a specific medicinal material and the fraction thereof have a remarkably excellent 5α reductase inhibitory effect, and thus completed the present invention. .
本明細書で、‘抽出物’は、各薬材の多様な器官、例えば、葉、花、茎、実、種子、根など、又は全草から抽出して得たものを意味する。
また、本明細書で、‘改善’とは、症状の予防又は治療はもとより、症状が表れた範囲の減少、症状進行の遅延又は緩和、症状の軽減又は安定化、部分的又は完全な回復、その他の有利な結果などのいずれも含む意味として使われ、特に、毛髪及び頭皮状態の改善を意味する。
より具体的に、前記毛髪及び頭皮状態の改善とは、望ましくは、脱毛予防又は治療(発毛促進)になり、また、望ましくは、皮脂分泌減少、頭垢防止又は頭皮炎症の防止になりうる。
本発明の望ましい一具体例による毛髪及び頭皮状態改善用組成物は、16種の薬材から選択された1種以上の抽出物を有効成分として含む。
前記薬材としては、蘆根、芍薬、茯神、石韋、ソバナ(薺バナ)、センナ葉、紫檀香、草果、沢瀉、貫衆、亜麻仁、葛花、きょうおう(姜おう)、かろにん(か楼仁)、麻仁及び蘇木があり、前記薬材についてより詳しく説明すれば、次の通りである。
In the present specification, the “extract” means one obtained by extracting from various organs of each medicine, for example, leaves, flowers, stems, fruits, seeds, roots, etc., or whole plants.
In this specification, 'improvement' means not only the prevention or treatment of symptoms, but also the reduction of the range of symptoms, delay or alleviation of symptom progression, reduction or stabilization of symptoms, partial or complete recovery, It is used in the sense of including any other advantageous results, and in particular, means an improvement in hair and scalp conditions.
More specifically, the improvement of the hair and scalp condition may desirably be prevention or treatment of hair loss (promotion of hair growth), and may desirably decrease sebum secretion, prevent scalp or prevent scalp inflammation. .
A composition for improving hair and scalp conditions according to a preferred embodiment of the present invention includes one or more extracts selected from 16 kinds of medicinal materials as active ingredients.
Examples of the chemicals include radish, glaze, god of gods, sarcophagus, sobana, senna leaves, rosewood incense, grasses, swamps, mulberry, flaxseed, kuzuhana, kyoou There are carrots, hemp seeds, and sugi, and the chemicals will be described in more detail as follows.
蘆根(Phragmites communis)は、葦の根茎であって、熱性疾患に有効であり、肺熱による咳嗽、肺結核、肺膿瘍、胃熱による嘔吐などを治療する薬材である。
芍薬(Paeoniae Radix)は、消化管運動能を亢進させて、消化、吸収を促進し、鎮痛、鎮痙、鎮静作用及び胃酸分泌の抑制効果があり、白芍薬、赤芍薬、胡芍葯、参芍薬など多様な品種を用いることができる。
Phragmites communis is a rhizome of cocoons that is effective for heat-related diseases and is a drug for treating cough due to lung fever, pulmonary tuberculosis, lung abscess, vomiting due to gastric fever, and the like.
Paeoniae Radix enhances gastrointestinal motility, promotes digestion and absorption, has analgesic, antispasmodic, sedative and gastric acid secretion inhibitory effects. Various varieties can be used.
茯神は、サルノコシカケ科の茯苓(Poria cocos)の中間に天然的に松根を抱いている白部分であって、心を静め、不眠症、健忘症などを治療する薬材として使われる。
石韋(Pyrrosia lingua(Thunberg)Farwell又は同属植物)は、葉と根に鎮咳、去痰、平喘作用があって、薬材として使われる。また、泌尿生殖器疾患として、淋疾、尿道炎、膀胱炎、腎炎などの症状に利尿・解熱効果を表し、尿道結石にも、他の薬物と配合して利用する。晩成気管支炎にも効果が認められ、急慢性腎炎、腎盂腎炎にも、消炎・利尿作用を表す。
The sacred god is a white part that naturally holds a pine root in the middle of the Poria cocos, and is used as a medicine to calm the mind and treat insomnia, amnesia and the like.
Sarcophagus (Pyrrosia lingua (Thunberg) Farwell or the same genus) has antitussive, expectorant and flattening effects on leaves and roots and is used as a medicine. In addition, as a urogenital disease, it exhibits diuretic and antipyretic effects on symptoms such as hemorrhoids, urethritis, cystitis, nephritis, etc. It is also used in combination with other drugs for urethral stones. It is also effective in the treatment of late-onset bronchitis, and also exhibits anti-inflammatory and diuretic effects in acute chronic nephritis and pyelonephritis.
ソバナ(薺バナ)(Adenophora remotiflora(Siebold&Zucc.)Miq.)は、根に熱を下げ、解毒し、痰を抑える効能があって、解毒、腫気治療、去痰などに使われる薬材である。
センナ葉(番瀉葉、Senna alexandrina)は、瀉下作用、抗菌、抗生及び箭毒様作用を有する。
Adenophora remoflora (Siebold & Zucc.) Miq. Is a drug used for detoxification, swelling treatment, expectoration, etc., which has the effect of lowering heat to the roots, detoxifying and suppressing wrinkles.
Senna leaves (Sena alexandrina) have a laxative action, antibacterial, antibiotic and venom-like action.
紫檀香は、紫檀(Pterocarpus santalinus Linne(豆科Leguminosae)の根幹であり、冷血、止血、解毒、消腫、止痛する効能があって、創傷出血や癰腫瘡毒に内服又は外用として使われる。
草果(Amomum tsao−ko Crevst et Lemaire)は、冷気を治し、腹を温め、嘔吐を止め、腹部脹滿を解消させる。これと同様に、痰を無くす効能があり、その他の腹痛、痰飮による脹滿症、胃癌による嘔吐、下痢などに用いられる。
Rosewood incense is the root of rosewood (Pterocarpus santalinus Linne (leguminous leguminosae)) and has the effect of cold blood, hemostasis, detoxification, antitumor, and pain relief, and is used as an internal or external application for wound bleeding and vaginosis.
Grass (Amoum tsao-ko Crevst et Lemaire) cures cold, warms the belly, stops vomiting, and eliminates abdominal distention. In the same way, it has the effect of eliminating sputum and is used for other abdominal pain, sputum due to sputum, vomiting due to stomach cancer, diarrhea and the like.
沢瀉(Alisma canaliculatum)は、塊根を乾かして薬材として使うが、身体の湿気を吸い込み、血糖と血圧とを落として糖尿病に効果があるだけではなく、血液中に老廃物とコレステロールとを除去して、血液の流れを良くする効能があって、腎臓炎、膀胱炎、尿道炎、糖尿、高血圧、脂肪肝などの症状に用いられる。 Arisuma canalicatum is used as a medicine by drying tuberous roots, but it not only inhales moisture in the body and lowers blood sugar and blood pressure, but is effective in diabetes, but also removes waste products and cholesterol in the blood. It has the effect of improving blood flow and is used for symptoms such as nephritis, cystitis, urethritis, diabetes, hypertension and fatty liver.
貫衆(Dryopteris crassirhizoma NAKAI)は、羊歯植物綿馬科に属する植物であって、貫衆の根茎は、その成分としてフィマロン(filmaron)、ロログルシノール(phloroglucinol)などが知られており、薬理効果としては、条虫治療剤、風邪治療剤などが知られている。 Dryopteris crushirhizoma NAKAI is a plant belonging to the ovine plant cottonseed family, and the rhizomes of the mushroom are known as components such as fimaron and phloroglucinol, and have pharmacological effects. As such, a tapeworm therapeutic agent, a cold therapeutic agent and the like are known.
亜麻仁は、亜麻科(Linaceae)に属する亜麻(Linum usitatissimum Linne)のよく熟した種であって、糖尿病と腸疾患の治療及び気管支のカタル性疾患に冷浸剤として用いられる。
葛花(Pueraria thunberginia)は、完全に開花していないつぼみを主に使い、飲みすぎによる頭痛、発熱、渇き、食慾不振、腹部膨満、及び嘔吐症に用いられる。
Flaxseed is a well-ripened species of flax (Linum usitatisimum Linne) belonging to the Linaceae family, and is used as a cold soaking agent in the treatment of diabetes and bowel disease and bronchial catarrhal disease.
Kuzuka (Pueraria thunberginia) is mainly used for buds that are not fully flowered, and is used for headaches, fever, thirst, anorexia, abdominal distension, and vomiting due to excessive drinking.
きょうおう(姜おう)(Curcuma longa)は、ショウガ科に属する多年生本草の根茎を乾燥したものであって、おけつ(お血)をなくし、気の流れを円滑にし、月経の時期を経ても出ないことを順調に通じるようにし、疼痛を止める効能を有する薬材である。 Curcuma longa is a dried rhizome of perennial herbs belonging to the family Ginger, which eliminates blood (blood), smoothes the flow of air, and passes through the menstrual period. It is a medicinal material that has the effect of stopping pain and making it easy to communicate that it does not occur.
かろにん(か楼仁)は、ウリ科のチョウセンカラスウリ(Trichosanthes kirilowii Maximowicz)又はキカラスウリ(Trichosanthes kirilowii Max.var.japonica Kitamura)の種を言い、痰熱咳嗽、便秘、腫気、乳汁分泌促進などの効果がある。特に、熱性気管支炎で痰がよく吐かれない時、肺を補し、柔らかくし、気を下って痰をなくし、急性気管支炎、肋膜炎、肺炎などに効果がある。 Karonin refers to the species of cucurbits of the cucurbitaceae (Trichosanthes kirirowii Maximowicz) or Trichosanthes kirirowiii Max. Var. Japonica Kitamura fever, There are effects such as. In particular, when fistula does not vomit well due to febrile bronchitis, it supplements and softens the lungs, lowers wrinkles and eliminates sputum, and is effective for acute bronchitis, pleurisy, pneumonia, etc.
麻仁は、麻(Cannabis sativa)の種であって、脂肪が豊かであり、つやがあって、乾いたものを潤沢にし、腸を柔らかに疏通するように助け、血液循環を順調にする効能があると知られており、難産、腫痛などに鎮痛剤として用いられる。 Hemp (Cannabis sativa) is a seed of cannabis sativa that is rich in fat, shiny, moisturized dry, helps the intestines softly pass, and has a smooth blood circulation effect It is known to be used as an analgesic for dystocia and tumor pain.
蘇木(Caesalpinia sappan L.)は、豆科(Leguminosae)に属する植物であって、蘇方木、蘇方、赤木、紅紫などと呼ばれ、大韓民国には自生しておらず、中国の福建省、広東省、広西省、貴州省、雲南省、海南島、台湾などに分布している。蘇木の茎と太い枝の心材を蘇木と言い、心臓と血管とに対する作用、中枢抑制作用、抗菌作用、血糖低下作用を有することが知られている。 Sugi (Caesalpinia sappan L.) is a plant belonging to the Leguminosae family, and is called Sukatagi, Sukata, Akagi, Red Purple, etc. , Guangdong, Guangxi, Guizhou, Yunnan, Hainan Island, Taiwan and so on. The heart material of the stem and thick branch of the tree is called a tree, and is known to have an action on the heart and blood vessels, a central inhibitory action, an antibacterial action, and a blood glucose lowering action.
本発明の一具体例による毛髪及び頭皮状態改善用組成物は、5α還元酵素阻害活性に優れた前記16種の薬材のうち、1種以上の抽出物を有効成分として含むことによって、毛髪及び頭皮の状態を著しく改善しうる。望ましくは、蘆根、芍薬、茯神、石韋、麻仁及び蘇木の抽出物を含みうる。
一方、前記抽出物のうち、蘆根、芍薬、茯神、葛花及び蘇木の抽出物は、望ましくは、粉末の形態で含まれ、石韋、ソバナ(薺バナ)、センナ葉、紫檀香、草果、沢瀉、貫衆、亜麻仁、及びきょうおう(姜おう)の抽出物は、望ましくは、エキスの形態で含まれ、かろにん(か楼仁)の抽出物は、オイルの形態で含まれ、また、麻仁の抽出物は、薄い液体の形態で含まれる。
The hair and scalp condition improving composition according to an embodiment of the present invention includes one or more extracts among the 16 kinds of medicines having excellent 5α reductase inhibitory activity as an active ingredient. It can significantly improve the condition of the scalp. Desirably, it can include extracts of roots, glazes, gods of deity, stalagmites, hemp seeds, and sugi.
On the other hand, among the above-mentioned extracts, the extracts of radish, glaze, 茯神, kuzuhana and soki are preferably included in the form of powder, and are sarcophagus, sobana, senna leaf, rosewood incense. , Grasses, swamps, intruders, flaxseed, and cucumber extracts are preferably included in the form of extracts, and the extract of karo nin is in the form of oil. In addition, the extract of hemp seed is included in the form of a thin liquid.
前記毛髪及び頭皮状態改善用組成物は、各分野別に通常使われる方法によって適切な担体、賦形剤、及び希釈剤などを更に含み、薬学組成物、機能性食品組成物、又はヘア組成物として適用可能である。
薬学組成物として提供される場合、前記組成物は、通常の方法によって経口又は非経口で投与され、例えば、経口投与時には、散剤、顆粒剤、錠剤、懸濁剤、エマルジョン、シロップなどの剤形として使われる。
望ましい投与量は、投与対象及び/又は疾患の治療又は予防に適した含量であり、これは、投与対象の年齢、性別、一般健康状態及び体重、疾病の種類及び重症度、剤形の種類、組成物に含有された他の成分の種類及び含量、組成物の分泌率、投与経路及び期間などを含めた多様な因子によって調節され、当業者によって適切に選択されうる。前記投与対象は、ヒトを含む哺乳類である。
The composition for improving hair and scalp conditions further comprises a suitable carrier, excipient, diluent and the like according to a method usually used for each field, and is used as a pharmaceutical composition, functional food composition, or hair composition. Applicable.
When provided as a pharmaceutical composition, the composition is administered orally or parenterally by conventional methods. For example, when administered orally, dosage forms such as powders, granules, tablets, suspensions, emulsions, and syrups are used. Used as
The desired dosage is a content suitable for the subject of administration and / or treatment or prevention of the disease, and this includes the age, sex, general health status and weight of the subject of administration, the type and severity of the disease, the type of dosage form, It can be adjusted by various factors including the type and content of other ingredients contained in the composition, the secretion rate of the composition, the route of administration and the duration, and can be appropriately selected by those skilled in the art. The administration subject is a mammal including a human.
前記組成物がヘア組成物の形態で提供される場合、望ましくは、前記毛髪及び頭皮状態改善用組成物を、ヘア組成物の全体重量を基準にして、0.0001〜99.9重量%、更に望ましくは、0.1〜50重量%含有する。望ましくは、前記組成物は、ヘアトナー、ヘアローション、ヘアクリーム、ヘアスプレー、ヘアムース、ヘアゲル、ヘア石鹸、ヘアシャンプー、ヘアリンス、ヘアパック、及びヘアトリートメントからなる群から選択された剤形で提供されうる。
本発明の他の望ましい一具体例として、5α還元酵素阻害活性に優れた前記16種の薬材のうち、1種以上の抽出物を、脱毛を有した個体に投与する段階を含む毛髪及び頭皮状態改善方法が提供される。
When the composition is provided in the form of a hair composition, preferably the hair and scalp condition improving composition is 0.0001-99.9% by weight, based on the total weight of the hair composition, More desirably, the content is 0.1 to 50% by weight. Desirably, the composition may be provided in a dosage form selected from the group consisting of hair toner, hair lotion, hair cream, hair spray, hair mousse, hair gel, hair soap, hair shampoo, hair rinse, hair pack, and hair treatment. .
As another desirable specific example of the present invention, the hair and scalp including the step of administering one or more extracts among the 16 kinds of medicines excellent in 5α reductase inhibitory activity to an individual having hair loss. A state improvement method is provided.
前記‘投与’する段階は、経口又は非経口投与からなり、非経口投与時に、皮膚外用、皮下注射注入方式、経皮投与、局所投与などを選択することができるが、これに制限されるものではない。望ましくは、皮膚外用として使うものであって、皮膚に塗布する方法を利用できる。
局所投与の場合、軟膏、クリーム又はゲルのように、半固形(semisolid)製剤を用いて投与し、経皮投与の場合、マトリックス又はレザボア型パッチ(reservoir patch)だけではなく、半固形製品(水性アルコール性ゲルなど)も利用され、これに制限されるものではない。
The step of “administering” comprises oral or parenteral administration, and at the time of parenteral administration, external use for skin, subcutaneous injection, transdermal administration, topical administration, etc. can be selected, but this is not limited thereto. is not. Desirably, it is used for external use on the skin, and a method of applying to the skin can be used.
For topical administration, it is administered using a semisolid formulation, such as an ointment, cream or gel, and for transdermal administration, not only a matrix or reservoir patch, but also a semisolid product (aqueous) Alcoholic gels and the like) are also used and are not limited thereto.
本発明の望ましい更に他の一具体例によって、前記毛髪及び頭皮状態改善用組成物の製造方法が提供される。
前記製造方法は、望ましくは、蘆根、芍薬、茯神、石韋、ソバナ(薺バナ)、センナ葉、紫檀香、草果、沢瀉、貫衆、亜麻仁、葛花、きょうおう(姜おう)、かろにん(か楼仁)、麻仁及び蘇木からなる群から選択された1種以上を水、エタノール、又はこれらの混合溶媒で抽出する段階と、前記抽出段階を通じて得られた抽出物を減圧濾過する段階と、前記濾過段階を通じて得られた濾液を減圧濃縮する段階と、を含んでなる。
According to still another preferred embodiment of the present invention, a method for producing the hair and scalp condition improving composition is provided.
Preferably, the manufacturing method is preferably radish, glaze, 茯神, stone 韋, sobana, senna leaf, rosewood incense, grass, swamp, mulberry, flaxseed, kuzuhana, kyoou. A step of extracting one or more selected from the group consisting of karo-nin (karoujin), hemp and sugi with water, ethanol, or a mixed solvent thereof, and an extract obtained through the extraction step And filtration of the filtrate obtained through the filtration step under reduced pressure.
前記各薬材は、抽出効率をより高めるために、望ましくは、抽出段階以前に粉砕する工程を経て、特に、前記薬材のうち、実又は種子などの形態を有するものは、例えば、はさみなどの道具を使って、切断した以後に粉砕して使うことができる。粉砕方法としては、特に制限されず、例えば、ミキサー機などの多様な道具を用いることができる。
望ましくは、前記抽出段階は、それぞれの薬材を別途に抽出するか、又はあらゆる薬材を混合して混合物の状態で抽出する方法でなされ、各薬材を別個に抽出して使う場合、抽出溶媒は、互いに同一又は異なっていてもよい。
In order to further increase the extraction efficiency, each of the chemicals is desirably subjected to a step of pulverization before the extraction stage. In particular, among the chemicals, those having a form such as fruit or seed are, for example, scissors. The tool can be used after being cut and crushed. The pulverization method is not particularly limited, and for example, various tools such as a mixer machine can be used.
Preferably, the extraction step is performed by a method of extracting each chemical separately or by mixing all the chemicals and extracting them in a mixture state. The solvents may be the same or different from each other.
また、望ましくは、前記抽出段階は、それぞれの薬材又はこれらの混合物を抽出溶媒と混合した後、浸出する方法でなされる。
前記浸出は、望ましくは、30〜40℃の温度範囲内、より望ましくは、33〜38℃の温度でなされ、望ましくは、1〜3日間、より望ましくは、45〜50時間なされうる。
抽出溶媒は、特に制限されるものではないが、望ましくは、水、エタノール、又はこれらの混合溶媒を使って抽出し、より望ましくは、エタノール、最も望ましくは、60〜80%(v/v)のエタノールを使うことができる。
また、望ましくは、前記抽出溶媒は、薬材100g当たり400〜800mLで使うことができる。
Preferably, the extraction step is performed by leaching after mixing each drug substance or a mixture thereof with an extraction solvent.
The leaching is desirably performed within a temperature range of 30 to 40 ° C., more desirably at a temperature of 33 to 38 ° C., desirably 1 to 3 days, and more desirably 45 to 50 hours.
The extraction solvent is not particularly limited, but is preferably extracted using water, ethanol, or a mixed solvent thereof, more preferably ethanol, most preferably 60 to 80% (v / v). Of ethanol can be used.
In addition, preferably, the extraction solvent can be used in an amount of 400 to 800 mL per 100 g of the chemical.
前記減圧濾過段階は、特に制限されず、当業者に広く知られた方法を用いることができる。前記濾過段階を通じて得られた濾液は、望ましくは、減圧濃縮する段階を更に経ることができる。前記減圧濃縮段階は、特に制限されず、当業者に広く知られた方法を使ってなされ、前記段階以後に凍結乾燥する段階などをまた選択的に含みうる。 The vacuum filtration step is not particularly limited, and a method widely known to those skilled in the art can be used. The filtrate obtained through the filtration step may be further subjected to a concentration step under reduced pressure. The vacuum concentration step is not particularly limited, and is performed using a method widely known to those skilled in the art, and may optionally include a step of freeze-drying after the step.
以下、本発明を実施例によって詳しく説明する。但し、下記の実施例は、本発明を例示するものであり、本発明が、下記の実施例によって限定されるものではない。 Hereinafter, the present invention will be described in detail by way of examples. However, the following examples illustrate the present invention, and the present invention is not limited to the following examples.
実施例1.抽出物の製造
蘆根、芍薬、茯神、石韋、ソバナ(薺バナ)、センナ葉、紫檀香、草果、沢瀉、貫衆、亜麻仁、葛花、きょうおう(姜おう)、かろにん(か楼仁)、麻仁及び蘇木を準備して、それぞれ粉砕した。実や種子は、はさみで切った後、粉砕した。
1000mLボトル(Duran)に、前記粉砕された薬材100gと70%(v/v)エタノール(EtOH)600mLとを添加して混合した後、恒温水槽で、35℃で48時間浸出した。
得られた浸出物を濾過紙(Watman21番フィルター)を用いて減圧濾過した後、回収された濾液を減圧濃縮器で濃縮して、下記の表1に示すような生薬抽出物を得た(生薬によって、エキス、粉末の形態、薄い液体で回収)。製造された抽出物は、50mLチューブに分取後、パラフィルム(Parafilm)で封印して冷蔵保管した。
Example 1. Manufacture of extracts Sone, glaze, 茯神, 韋韋, sobana, senna leaf, rosewood incense, herbaceous fruit, swamp, sardine, flaxseed, kuzuhana, kyouou, karonin (Karoujin), hemp seed and Sugi were prepared and crushed. The fruits and seeds were cut with scissors and then crushed.
In a 1000 mL bottle (Duran), 100 g of the pulverized drug substance and 600 mL of 70% (v / v) ethanol (EtOH) were added and mixed, and then leached for 48 hours at 35 ° C. in a constant temperature water bath.
The obtained leachate was filtered under reduced pressure using filter paper (Watman No. 21 filter), and then the collected filtrate was concentrated with a vacuum concentrator to obtain herbal extracts as shown in Table 1 below (herbal medicine) Recovered in the form of extract, powder, thin liquid). The manufactured extract was collected in a 50 mL tube, sealed with Parafilm, and stored refrigerated.
実験例1.GC−MSを利用したテストステロンとDHTとの定量分析
反応後、抽出された肝ミクロソーム分画(liver microsomal fraction)でのテストステロンとジヒドロテストステロン(DHT)との定量分析のためのクロマトグラム(chromatogram)を、図1から図4に示した。
Experimental Example 1 After quantitative reaction of testosterone and DHT using GC-MS , chromatogram for quantitative analysis of testosterone and dihydrotestosterone (DHT) in the extracted liver microsome fraction (liver microsomal fraction) 1 to FIG. 4.
実験例2.5α還元酵素の抑制効能の評価測定
前記実施例1を通じて得られた抽出物の5α還元酵素の抑制効能を評価するために、まず、対照薬物として、フィナステリド(finasteride)(Merck)を用いてミクロソーム分画(microsomal fraction)抽出条件を確立した。
具体的に、前記フィナステリドを均質器(Homogenizer)、tissue homogenize kit、TissueLyzerにそれぞれ分画して、分画物を得て、これを対象にして比較実験して、下記の表2の結果を得た。
Experimental Example 2.5 Evaluation and Measurement of Inhibitory Efficacy of α-Reductase In order to evaluate the inhibitory efficacy of 5α-reductase of the extract obtained through Example 1, first, as a control drug, finasteride (Merck) was used. Used to establish the extraction conditions for microsomal fractions.
Specifically, the finasteride is fractionated into a homogenizer, a tissue homogenizer kit, and a tissue lyzer to obtain fractions, and comparative experiments are performed on the fractions to obtain the results shown in Table 2 below. It was.
Homogenizerによる分画物を2回繰り返し実験して、5α還元酵素の抑制効能の評価に対する再現性を下記の表3に示すように確認した。 The fraction obtained with the homogenizer was repeatedly tested twice, and the reproducibility for the evaluation of the inhibitory effect of 5α reductase was confirmed as shown in Table 3 below.
実験例3.天然抽出物の5α還元酵素の抑制効能の評価
前記実施例1を通じて得られた天然抽出物の5α還元酵素の抑制効能を評価するために、それぞれの天然抽出物とテストステロンとをそれぞれDMSOとメタノール(MeOH)とに溶かして用いた。
まず、2つの有機溶媒に対する影響を調べるために、100μg/mLテストステロン溶液をDMSOとメタノール(MeOH)とにそれぞれ10μg/mLの濃度で希釈して、比較実験し、その結果を下記の表4に表した。
Experimental Example 3. Evaluation of inhibitory efficacy of 5α reductase of natural extract In order to evaluate the inhibitory efficacy of 5α reductase of the natural extract obtained through Example 1, each natural extract and testosterone were mixed with DMSO and methanol ( MeOH) and used.
First, in order to investigate the influence on two organic solvents, a 100 μg / mL testosterone solution was diluted with DMSO and methanol (MeOH) at a concentration of 10 μg / mL, respectively, and a comparative experiment was conducted. The results are shown in Table 4 below. expressed.
構築された5α還元酵素の効能分析方法を活用して、前記実施例1によって得られた16種の天然抽出物と対照群として、前記実施例1と同じ方法で抽出して得られた龍眼肉抽出物、赤小豆抽出物、及び酸棗仁抽出物を使って、5α還元酵素の抑制効能を2回繰り返し実験して、下記の表5−1及び表5−2に表した。 Using the constructed method for analyzing the efficacy of 5α reductase, 16 natural extracts obtained in Example 1 and a control group were extracted by the same method as in Example 1 as a control group. Using the extract, the red bean extract, and the acid vinegar extract, the inhibitory effect of 5α reductase was repeated twice, and the results are shown in Tables 5-1 and 5-2 below.
前記表5−1及び表5−2に表したように、本発明の実施例1によって得られた薬材16種の抽出物は、5α還元酵素の効能が全く表れず、5α還元酵素の抑制効能に優れることを確認できた。一方、対照群である龍眼肉抽出物、赤小豆抽出物、及び酸棗仁抽出物では、使われた濃度と無関係に5α還元酵素の抑制効能がないということを確認することができた。特に、本発明の16種の天然抽出物は、いずれも既存に知られた陽性対照群(positivecontrol)である苦参と同じく、5α還元酵素の抑制効能に優れるということが分かった。 As shown in Table 5-1 and Table 5-2, the extract of 16 kinds of medicines obtained by Example 1 of the present invention does not show any efficacy of 5α reductase, and inhibits 5α reductase. It was confirmed that the efficacy was excellent. On the other hand, it was confirmed that the control group, longan meat extract, red bean extract, and acid soy sauce extract, had no inhibitory effect on 5α reductase regardless of the concentration used. In particular, it was found that all of the 16 natural extracts of the present invention are excellent in the inhibitory effect of 5α reductase, as is the case with bitterness which is a known positive control group (positive control).
実験例4.本発明の組成物を利用したマウス毛髪成長促進効果の測定
本発明による脱毛防止及び毛髪成長促進用組成物の効果を調べるために、C57BL/6Nマウスを用いて本組成物の毛髪成長促進効果を確認した。前記脱毛防止及び毛髪成長促進用組成物は、麻仁抽出物及び蘇木抽出物を用いた。C57BL/6Nマウスが二番目の退行期(catagen)に入る生後7週齢マウスの毛を完全に除毛した後、本発明の組成物と対照物質とをマウス10匹ずつ150μLずつ1日1回連続して5週間塗布した。経時的な毛髪成長促進程度を肉眼で比較して、結論を出した(図5)。陰性対照群としては、毛髪成長促進効果のない80%エタノールを使い、陽性対照群としては、3%ミノキシジルを使った。下記の表6は、経時的な毛髪の成長程度を、肉眼観察を通じて比較分析した表である。
Experimental Example 4 Measurement of mouse hair growth promoting effect using the composition of the present invention In order to examine the effect of the composition for preventing hair loss and promoting hair growth according to the present invention, the effect of promoting hair growth of this composition using C57BL / 6N mice was examined. confirmed. The composition for preventing hair loss and promoting hair growth used a hemp extract and a soy extract. After completely removing the hair of 7-week-old mice C57BL / 6N mice entering the second stage of catagen, 150 μL of the composition of the present invention and control substance once per day for 10 mice. It was applied continuously for 5 weeks. The degree of hair growth promotion over time was compared with the naked eye and a conclusion was drawn (FIG. 5). As a negative control group, 80% ethanol having no hair growth promoting effect was used, and as a positive control group, 3% minoxidil was used. Table 6 below is a table in which the degree of hair growth over time is comparatively analyzed through visual observation.
実験例5.発毛面積の測定
前記実験例4を通じて得られた発毛測定写真を除毛面積に対する発毛面積の比率を測定するために、イメージ分析プログラムであるi−Solution Liteを使った。まず、除毛された全体面積を測定し、発毛された面積を測定した後、全体面積に対する百分率(%)で発毛比率を測定した。下記の表7に経時的な除毛面積に対する毛髪の成長比率を表した。
Experimental Example 5. Measurement of hair growth area In order to measure the ratio of the hair growth area to the hair removal area of the hair growth measurement photograph obtained through Experimental Example 4, i-Solution Lite, an image analysis program, was used. First, after measuring the total area of hair removal and measuring the area of hair growth, the hair growth ratio was measured as a percentage (%) with respect to the total area. Table 7 below shows the hair growth ratio with respect to the hair removal area over time.
Claims (9)
前記抽出段階を通じて得られた抽出物を減圧濾過する段階と、
前記濾過段階を通じて得られた濾液を減圧濃縮する段階と、
を含む請求項1から4のいずれかに記載の毛髪及び頭皮状態改善用組成物の製造方法。 Sone, glaze, god of god, stone wall, sobana, senna leaf, rosewood incense, grass, swamp, incense, flaxseed, kuzuhana, kyouou, karonin ), Extracting one or more selected from the group consisting of hemp and sugi with water, ethanol, or a mixed solvent thereof;
Filtering the extract obtained through the extraction step under reduced pressure;
Concentrating the filtrate obtained through the filtration step under reduced pressure;
The manufacturing method of the composition for hair and scalp condition improvement in any one of Claim 1 to 4 containing this.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20120080458 | 2012-07-24 | ||
KR10-2012-0080458 | 2012-07-24 | ||
KR1020130086685A KR20140015199A (en) | 2012-07-24 | 2013-07-23 | Composition for improving condition of hair and scalp comprising natural extracts |
KR10-2013-0086685 | 2013-07-23 | ||
PCT/KR2013/006585 WO2014017804A1 (en) | 2012-07-24 | 2013-07-23 | Composition comprising natural extracts as active ingredients for improving condition of hair and scalp, and method for preparing same |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2015520228A true JP2015520228A (en) | 2015-07-16 |
Family
ID=50264914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015518348A Pending JP2015520228A (en) | 2012-07-24 | 2013-07-23 | Composition for improving hair and scalp conditions containing natural extract as active ingredient, and method for producing the same |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2015520228A (en) |
KR (1) | KR20140015199A (en) |
CN (1) | CN104411320A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114588093A (en) * | 2021-12-27 | 2022-06-07 | 华南农业大学 | Application of amomum tsao-ko in preparing shampoo |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2447672B (en) | 2007-03-21 | 2011-12-14 | Ford Global Tech Llc | Vehicle manoeuvring aids |
KR101818500B1 (en) * | 2016-02-18 | 2018-01-15 | 한국 한의학 연구원 | Composition for preventing, improviong or treating disease caused by side effect of anticancer agent comprising Phragmites communis Trin extract as effective component |
KR101917733B1 (en) | 2017-12-19 | 2018-11-13 | 게놈앤메디신(주) | A composition for preventing, treating or improving a prostate disease, which comprisesd of extracts of Acanthopanax sessiliflorus, Phragmitis Rhizoma, and Pinus densiflora as an active ingredients |
KR102068068B1 (en) | 2019-04-12 | 2020-01-20 | 주식회사 씨엠컴퍼니 | Composition containing natural extracts for scalp and hair, and method for manufacturing the same |
KR102316407B1 (en) * | 2019-11-22 | 2021-10-21 | 광주여자대학교 산학협력단 | cosmetic composition using Nandina domestica Thunb |
KR102316415B1 (en) * | 2019-11-22 | 2021-10-21 | 광주여자대학교 산학협력단 | manufacturing method of cosmetic composition using Nandina domestica Thunb |
KR102405458B1 (en) | 2019-12-16 | 2022-06-07 | 주식회사 퍼슨 | Cosmetic composition for preventing hair loss and promoting hair growth containing alfalfa extract, hair cosmetic including the same, and method of manufacturing the same. |
KR102492903B1 (en) * | 2020-10-19 | 2023-01-30 | 주식회사 가인화장품 | Anti-bacterial composition and cosmetic composition for improving of dandruff or acne comprising the same |
KR102591508B1 (en) * | 2021-02-23 | 2023-10-19 | 주식회사 가인화장품 | Anti-bacterial composition and cosmetic composition for improving of dandruff or acne comprising the same |
KR102562486B1 (en) * | 2021-07-14 | 2023-08-01 | 동의대학교 산학협력단 | A composition that does not irritate the skin and has excellent skin moisture containing the extract of Pyrrosia hastata (Thunb. ex Houtt.) Ching as an active ingredient |
KR102558832B1 (en) * | 2022-09-28 | 2023-07-25 | (주)메디치코리아코스메틱 | Composition for hair decoloration agent |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11246336A (en) * | 1998-02-27 | 1999-09-14 | Ichimaru Pharcos Co Ltd | Activated oxygen scavenger and skin beautifying cosmetic composition |
CN101199769B (en) * | 2007-12-18 | 2010-06-09 | 申华 | External medicament for treating baldness and preparing method thereof |
-
2013
- 2013-07-23 CN CN201380029691.1A patent/CN104411320A/en active Pending
- 2013-07-23 KR KR1020130086685A patent/KR20140015199A/en not_active Application Discontinuation
- 2013-07-23 JP JP2015518348A patent/JP2015520228A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11246336A (en) * | 1998-02-27 | 1999-09-14 | Ichimaru Pharcos Co Ltd | Activated oxygen scavenger and skin beautifying cosmetic composition |
CN101199769B (en) * | 2007-12-18 | 2010-06-09 | 申华 | External medicament for treating baldness and preparing method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114588093A (en) * | 2021-12-27 | 2022-06-07 | 华南农业大学 | Application of amomum tsao-ko in preparing shampoo |
Also Published As
Publication number | Publication date |
---|---|
CN104411320A (en) | 2015-03-11 |
KR20140015199A (en) | 2014-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015520228A (en) | Composition for improving hair and scalp conditions containing natural extract as active ingredient, and method for producing the same | |
KR101544532B1 (en) | Composition comprising an extract of Cynanchi wilfordii for preventing or treating of climacteric disorder | |
CN106214592B (en) | Hair follicle nutrient liquor composition and preparation method thereof | |
Tadiwos et al. | Analgesic and anti-inflammatory activities of 80% methanol root extract of Jasminum abyssinicum Hochst. ex. Dc.(Oleaceae) in mice | |
WO2004052383A1 (en) | An composition containing triterpenoid saponins extracted from bamboo, and the preparation method and use thereof | |
KR20090005479A (en) | Composition for promoting hair growth | |
Prakash et al. | Gentiana lutea Linn.(yellow gentian): a comprehensive | |
US9554985B2 (en) | Agent for promoting hair growth and method for preparing same | |
KR101829892B1 (en) | A cosmetic composition comprising fraxinus rhynchophylla extract and calystegia soldanella extract | |
KR102326660B1 (en) | Compositions for preventing hair loss, promoting hair growth and increasing hair thickness comprising herbal extracts | |
CN103041042B (en) | Tibetan medicine composition and application of composition in anti-off hair products | |
KR101412500B1 (en) | Cosmetic composition for improving atopic skin comprising herb extract fermented in bamboo cylinder and manufacturing method thereof | |
CN105939703B (en) | Shampoo composite containing indigenous plant and Chinese herbal medicine extract | |
Verma et al. | A Scientific Update on Juglans Regia Linn. | |
CN110101776A (en) | A kind of Tibetan medicinal composition of hair-growing and anti-hair loss and preparation method thereof | |
KR101829891B1 (en) | A cosmetic composition comprising osmanthus asiaticus extract and clematis apiifolia extract | |
Petrović et al. | Significance and efficacy of triterpene saponin herbal drugs with expectorant action in cough therapy | |
Mikaili et al. | Pharmacological review of medicinal trees spontaneous in Iran: a historical and modern study | |
KR20190027178A (en) | A cosmetic composition comprising centipeda minima extract | |
WO2017051950A1 (en) | Method for manufacturing oriental medicinal soap for improving atopic dermatitis | |
CN111840416A (en) | Marrow-washing bone-setting liquid | |
Nazim et al. | Hansraj (Adiantum capillus-veneris)-A review | |
KR101833776B1 (en) | Composition for Preventing Alopecia and Improving Hair Growth Comprising the Extract of Anemarrhena Asphodeloides and Aralia Elata | |
KR20140148227A (en) | Composition for preventing depilation and hair growth promotion and Method of preparing thereof | |
KR20040065498A (en) | Allergic dermatitis and skin itching relieving composition containing natural herb extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20141222 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150929 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20151221 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160128 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160225 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20160607 |